PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo - Brown, EJ; Balaguer-Lluna, L; Cribbs, AP; Philpott, M; Campo, L; Browne, M; Wong, JF; Oppermann, U; Carcaboso, AM; Bullock, AN; Farnie, G (Scientific Reports, 2024)